Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Endofill AB
AB
Active
Org 5593937484
Hantverkargatan 10
Dental practice care activities · NACE 8623
Est. 2022
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 36K
EBITDA margin
-3124.5%
-5811% vs 2024
Equity ratio
63.9%
Financial strength
Net profit 2025
SEK 1,5M
+118516% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
-1M
2023
0M
+100%
2024
-1M
-100%
2025
Key figures
Annual report 2025
Revenue
SEK 36K
—
EBITDA
SEK -1,1M
-5811%
Net profit
SEK 1,5M
+118516%
Total assets
SEK 3,7M
+77%
Equity
SEK 2,4M
+113%
Employees
1
—
Company information
Legal name
Endofill AB
Org number
5593937484
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
24 augusti 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Tandläkarverksamhet i form av specialistvård samt estetiska injektioner
Contact
Address
Hantverkargatan 10
Email
endofillab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Dental practice care activities
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
-1M
2023
0M
2024
-1M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
36
0
36
Staff expenses
−753
−0
−1 022
EBITDA
−848
−19
−1 125
Depreciation & amort.
—
—
—
EBIT
−848
−19
−1 161
Net financials
3 479
24
3 602
Profit before tax
1 972
5
1 841
Tax
−411
−4
−384
Net profit
1 561
1
1 457
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
2 602
2 079
3 682
Equity
1 586
1 107
2 354
Long-term debt
—
—
—
Short-term debt
356
312
67
Total debt
356
312
67
Financial ratios
5-year trend
EBITDA margin
-3124.5%
This company
15.8%
Market median
-19875% vs market
2023
2025
Equity ratio
63.9%
This company
38.2%
Market median
+67% vs market
2023
2025
Return on equity
61.9%
This company
18.4%
Market median
+236% vs market
2023
2025
Net profit margin
4046.1%
This company
8.1%
Market median
+49852% vs market
2023
2025
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
2023
2025
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-08-24 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
CA
Cesar Ariastam
Board of Directors
2022
HK
Hadis Khorshidian
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Endofill AB also hold positions in
0
other companies.
Person
Role here
Other companies
Cesar Ariastam
Board of Directors
0 companies
Hadis Khorshidian
Deputy Board Member
0 companies